Journal Of Assisted Reproduction And Genetics

The Journal of Assisted Reproduction and Genetics publishes cellular, molecular, genetic, and epigenetic discoveries advancing our understanding of the biology and underlying mechanisms from gametogenesis to offspring health. Special emphasis is placed on the practice and evolution of assisted reproduction technologies (ARTs) with reference to the diagnosis and management of diseases affecting fertility. Our goal is to educate our readership in the translation of basic and clinical discoveries made from human or relevant animal models to the safe and efficacious practice of human ARTs. The scientific rigor and ethical standards embraced by the JARG editorial team ensures a broad international base of expertise guiding the marriage of contemporary clinical research paradigms with basic science discovery. JARG publishes original papers, minireviews, case reports, and opinion pieces often combined into special topic issues that will educate clinicians and scientists with interests in the mechanisms of human development that bear on the treatment of infertility and emerging innovations in human ARTs. The guiding principles of male and female reproductive health impacting pre- and post-conceptional viability and developmental potential are emphasized within the purview of human reproductive health in current and future generations of our species.

The journal is published in cooperation with the American Society for Reproductive Medicine, an organization of more than 8,000 physicians, researchers, nurses, technicians and other professionals dedicated to advancing knowledge and expertise in reproductive biology.

《辅助生殖与遗传学杂志》发表细胞、分子、遗传和表观遗传学发现，以增进我们对从配子发生到后代健康的生物学和潜在机制的理解。特别强调辅助生殖技术 (ART) 的实践和发展，参考影响生育力的疾病的诊断和管理。我们的目标是教育我们的读者，将人类或相关动物模型的基础和临床发现转化为人类 ART 的安全有效实践。JARG 编辑团队秉承的科学严谨性和道德标准确保了广泛的国际专业知识基础，指导当代临床研究范式与基础科学发现的结合。JARG 出版原创论文、小型评论、病例报告和观点文章，通常结合成专题，以教育对与不孕症治疗和人类 ART 新兴创新有关的人类发育机制感兴趣的临床医生和科学家。在当代和未来几代人类生殖健康的范围内，强调了影响受孕前和受孕后生存能力和发育潜力的男性和女性生殖健康的指导原则。

该期刊与美国生殖医学学会合作出版，该学会由 8,000 多名医生、研究人员、护士、技术人员和其他专业人员组成，致力于提高生殖生物学的知识和专业技能。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-妇产科学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.2，平均审稿速度为 约1月 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。